HUTCHMED (CHINA) LS-,1 revenue breakdown overview

HUTCHMED (CHINA) LS-,1 revenue for the last year amounted to 759.24 M EUR, the most of which — 330.97 M EUR — came from its highest performing source at the moment, Oncology/Immunology - Research and Development, the year earlier bringing 36.72 M EUR. The greatest contribution to the revenue figure was made by China — last year it brought HUTCHMED (CHINA) LS-,1 440.35 M EUR, and the year before that — 399.37 M EUR.